drugset / Trial / NCT00258141

Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects

NCT00258141

Phase 4 Unknown 30 enrolled J. Uriach and Company
RandomizedCrossoverDouble-blindPrevention

Summary

The study will find out how effective rupatadine is in the treatment of mosquito bite symptoms in adult patients allergic to mosquito bites.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Rupatadine Small molecule 10 mg

Indications